MedPath

Warfarin Sodium

These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets, for oral useInitial U.S. Approval: 1954

Approved
Approval ID

b2728b7c-ae6e-49f6-b21b-335db78f4c49

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 6, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Warfarin Sodium

PRODUCT DETAILS

NDC Product Code50090-5004
Application NumberANDA040616
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 30, 2021
Generic NameWarfarin Sodium

INGREDIENTS (8)

WARFARIN SODIUMActive
Quantity: 7.5 mg in 1 1
Code: 6153CWM0CL
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10 ALUMINUM LAKEInactive
Code: CQ3XH3DET6
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Warfarin Sodium - FDA Approval | MedPath